COVID-19 in patients with neuroendocrine neoplasms – Two-year results of a worldwide survey (The INTENSIVE study)

#3674

Introduction: Preliminary results regarding 85 patients of the INTENSIVE study have been published in 2021.

Aim(s): To report the 2-year analysis data from patients enrolled between June 01, 2020, and May 31, 2022.

Materials and methods: This is a retrospective/prospective worldwide study on patients with neuroendocrine neoplasms (NENs) and molecularly proven SARS-CoV-2 positivity.

Conference:

Presenting Author: Gervaso L

Authors: Fazio N, Gervaso L, Halfdanarson T, Sonbol M, Pusceddu S,

Keywords: neuroendocrine, NEN, COVID-19, SARS-CoV-2,